DLB (Dolby Laboratories, Inc.Class A) Stock Analysis - Politician Trades
Dolby Laboratories, Inc.Class A (DLB) is a publicly traded Technology sector company. As of May 20, 2026, DLB trades at $53.50 with a market cap of $5.14B and a P/E ratio of 21.34. DLB moved +0.34% today. Year to date, DLB is -15.99%; over the trailing twelve months it is -30.63%. Its 52-week range spans $53.20 to $89.66. Analyst consensus is strong buy with an average price target of $87.50. Rallies surfaces DLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded DLB stock?
Recent politician trading activity in DLB includes disclosures from Lisa McClain, Lisa McClain, and Lisa McClain. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
DLB Key Metrics
Key financial metrics for DLB
Metric
Value
Price
$53.50
Market Cap
$5.14B
P/E Ratio
21.34
EPS
$2.51
Dividend Yield
0.36%
52-Week High
$89.66
52-Week Low
$53.20
Volume
324.33K
Avg Volume
0
Revenue (TTM)
$1.34B
Net Income
$242.10M
Gross Margin
87.86%
Congressional Trades in DLB
Lisa McClain sale (full) DLB on Sep 25, 2025 (amount: $15.00K) for Spouse.
Lisa McClain purchase DLB on Sep 11, 2025 (amount: $15.00K) for Spouse.
Lisa McClain sale DLB on Aug 4, 2025 (amount: $15.00K) for Spouse.
Recent politician trading activity in DLB includes disclosures from Lisa McClain, Lisa McClain, and Lisa McClain. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in DLB?
Yes. Rallies tracks politician and congressional stock disclosures for DLB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is DLB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DLB. It does not provide personalized investment advice.